What Happened?
Shares of healthcare technology company GE HealthCare Technologies (NASDAQ: GEHC) jumped 1.7% in the morning session after RBC Capital Markets initiated coverage on the stock with an Outperform rating and an $80 price target.
The analyst argued that a recent selloff in the shares had gone too far. In its research note, RBC cited an attractive risk/reward at current share levels, believing GE HealthCare's portfolio of AI-enabled products positions it for accelerating growth. The firm also noted that increased research and development investment is driving order momentum, and a "strong backlog" should support growth later in 2026. The positive analyst view adds to recent momentum for the company, which recently received FDA clearance for its MIM Contour ProtegeAI+ 2.0 auto-contouring platform.
The shares were trading at $64.90, up 1.9% from the previous close.
Is now the time to buy GE HealthCare? Access our full analysis report here, it’s free.
What Is The Market Telling Us
GE HealthCare’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 11 months ago when the stock dropped 6.5% on the news that the company reported second-quarter results that revealed significant pressure on its profit margins, overshadowing an increase in its full-year guidance.
While GE HealthCare raised its full-year guidance and reported a 3% increase in revenue, investors honed in on signs of declining profitability. The company's adjusted EBIT margin, a key measure of operational profit, contracted to 14.6% from 15.3% in the prior year. This squeeze was attributed to the impact of tariffs, which productivity gains could not fully offset. The weakness was pronounced in major segments, as the Imaging division's EBIT fell by 10% and the Patient Care Solutions segment saw a significant 23% drop in EBIT. The market's negative reaction suggested these margin pressures overshadowed the company's otherwise positive outlook.
GE HealthCare is down 21.6% since the beginning of the year, and at $64.90 per share, it is trading 26.4% below its 52-week high of $88.16 from January 2026.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
